Abstract: Described herein is a preservative composition, which includes polylysine, and a medium chain fatty acid (C6-C14) or a 1-monoglyceride derivative thereof. The preservative composition is able to confer both bacterial resistance and fungal resistance without substantially including non-naturally derived products. Also described are methods of improving microbial resistance in food, beverage, cosmetic products and/or pharmaceutical products, and cosmetic compositions including the preservative composition described herein.

Abstract: A handle apparatus comprising void regions or attachment devices that accommodate the shape of surgical devices and imaging units such that the device is held securely and mechanically fixed to the imaging unit within the handle assembly.

Abstract: A system and method for supplying compressed air from an auxiliary power unit to a main engine starter motor. The inlet guide vanes are controlled using either first or second inlet guide vane control logic and the surge control valve is controlled using either first or second surge control valve control logic. When the first inlet guide vane control logic is used, the inlet guide vanes are positioned based on a demand signal, when the second inlet guide vane control logic is used, the inlet guide vanes are positioned based on a demand schedule, when the first surge control valve logic is used, the surge control valve can be commanded to repeatedly move to only a fully-closed position and a fully-open position, and when the second surge control valve logic is used, the surge control valve can be commanded to the fully-closed position only when maximum flow is commanded.

Abstract: A system and method for supplying compressed air from an auxiliary power unit to a main engine starter motor. The inlet guide vanes are controlled using either first or second inlet guide vane control logic and the surge control valve is controlled using either first or second surge control valve control logic. When the first inlet guide vane control logic is used, the inlet guide vanes are positioned based on a demand signal, when the second inlet guide vane control logic is used, the inlet guide vanes are positioned based on a demand schedule, when the first surge control valve logic is used, the surge control valve can be commanded to repeatedly move to only a fully-closed position and a fully-open position, and when the second surge control valve logic is used, the surge control valve can be commanded to the fully-closed position only when maximum flow is commanded.

Abstract: The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A?, R2 R3 and R5 are as defined herein. The present invention also relates to compositions comprising at least one Heterocycle-Substituted Tetracyclic Compound, and methods of using the Heterocycle-Substituted Tetracyclic Compounds for treating or preventing HCV infection in a patient.

Abstract: The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A?, R2 R3 and R5 are as defined herein. The present invention also relates to compositions comprising at least one Heterocycle-Substituted Tetra-cyclic Compound, and methods of using the Heterocycle-Substituted Tetracyclic Compounds for treating or preventing HCV infection in a patient.

Abstract: An aircraft engine system includes a main engine having a main engine speed; a starter coupled to the main engine and configured to drive the main engine with compressed air; and an auxiliary power unit (APU) system coupled to the starter and configured to provide the compressed air to the starter. The APU system includes an APU with a compressor to generate the compressed air, and an APU electronic control unit (ECU) coupled to the APU, the APU ECU configured to receive the engine speed of the main engine and to control operation of the APU to modify an amount of the compressed air to the starter based on the main engine speed.

Abstract: Thiophene-substituted tetracyclic compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein A, A?, R2, R3, R4 and R5 are as defined herein. The compositions comprising at least one thiophene-substituted tetracyclic compound, and methods of using the thiophene-substituted tetracyclic compounds for treating or preventing HCV infection in a patient are also provided.

Abstract: An aircraft engine system includes a main engine having a main engine speed; a starter coupled to the main engine and configured to drive the main engine with compressed air; and an auxiliary power unit (APU) system coupled to the starter and configured to provide the compressed air to the starter. The APU system includes an APU with a compressor to generate the compressed air, and an APU electronic control unit (ECU) coupled to the APU, the APU ECU configured to receive the engine speed of the main engine and to control operation of the APU to modify an amount of the compressed air to the starter based on the main engine speed.

Abstract: The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.

Abstract: The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.

Abstract: The present invention relates to novel heterocyclic compounds of Formulae (I): (Chemical formula should be inserted here as it appears on abstract in paper form) Formula (I) as disclosed herein, or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder.

Abstract: The present invention relates to novel heterocyclic compounds of Formulae (I): (Chemical formula should be inserted here as it appears on abstract in paper form) Formula (I) as disclosed herein, or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder.

Abstract: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Abstract: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Abstract: The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.

Abstract: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Abstract: The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.

Abstract: An embodiment of the present invention is a technique to perform floating-point operations for vector processing. An input queue captures a plurality of vector inputs. A scheduler dispatches the vector inputs. A plurality of floating-point (FP) pipelines generates FP results from operating on scalar components of the vector inputs dispatched from the scheduler. An arbiter and assembly unit arbitrates use of output section and assembles the FP results to write to the output section.

Abstract: A word game and method of playing the word game comprising providing a main word or phrase (“Theme Word”), and a group of existing words (“Puzzle Words”), wherein each letter from the Theme Word is used once to form a different word (“Solved Word”) when added to a Puzzle Word. In an embodiment, multiple letters from the Theme Word may be added to a single Puzzle Word to form a single Solved Word. The letters from the Theme Word may be added anywhere to the Puzzle Word in order to form a new Solved Word. In an embodiment, the order of the letters in Puzzle Word may not be changed. In another embodiment the letter from the Theme Word may not be added to the end of the Puzzle Word. The game will be considered solved when all of the letters of the Theme Word have been successfully combined once with a Puzzle Word such that each letter has been used with a Puzzle Word to form a Solved Word.